Watchlist Price Alert

Collegium Pharmaceutical ... (COLL)

NASDAQ: COLL · Real-Time Price · USD

29.82

-0.41 (-1.36%)

At close: May 19, 2025, 3:59 PM

29.83

0.03%

After-hours: May 19, 2025, 04:30 PM EDT

Collegium Pharmaceutical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	631.45M	566.77M	463.93M	276.87M	310.02M	296.7M	280.41M	28.48M	1.71M
Cost of Revenue	254.1M	240.6M	254.44M	126.25M	130.18M	193.66M	165.68M	2.6M	213K
Gross Profit	377.34M	326.17M	209.49M	150.62M	179.84M	103.04M	114.74M	25.88M	1.5M
Operating Income	169.9M	166.96M	-104.57M	-46.7M	-5.09M	-23.75M	-20.68M	-75.45M	-94.08M
Interest Income	13.98M	15.62M	1.05M	12K	232K	1.94M	1.69M	582K	n/a
Pretax Income	98.57M	75.73M	-28.85M	-3.37M	27.58M	-22.72M	-39.13M	-74.86M	-94.18M
Net Income	69.19M	48.16M	-25M	71.52M	26.75M	-8.15M	-39.13M	-74.86M	-94.18M
Selling & General & Admin	210.36M	159.21M	172.19M	118.96M	113.83M	116.45M	126.76M	92.76M	80.63M
Research & Development	n/a	n/a	3.98M	9.45M	9.77M	10.34M	8.66M	8.57M	14.95M
Other Expenses	-2.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-94K
Operating Expenses	210.36M	150.71M	176.17M	128.41M	123.6M	126.79M	135.42M	101.33M	95.58M
Interest Expense	73.97M	83.34M	63.21M	21.01M	28.88M	909K	20.13M	582K	94K
Selling & Marketing Expenses	n/a	7.41M	11.74M	4.19M	5.37M	116.45M	126.76M	92.76M	80.63M
Cost & Expenses	464.47M	399.81M	430.61M	254.66M	253.78M	320.45M	301.1M	103.92M	95.79M
Income Tax Expense	29.38M	27.58M	-3.85M	-74.89M	830K	-14.57M	-110.91M	-1.16M	94K
Shares Outstanding (Basic)	32.27M	33.74M	33.83M	34.94M	34.41M	33.45M	32.88M	30.27M	24.26M
Shares Outstanding (Diluted)	40.42M	41.79M	33.83M	41.05M	35.15M	33.45M	32.95M	30.27M	24.26M
EPS (Basic)	2.14	1.60	-0.74	2.05	0.78	-0.24	-1.19	-2.47	-3.88
EPS (Diluted)	1.86	1.29	-0.74	1.86	0.76	-0.24	-1.19	-2.47	-3.88
EBITDA	341.7M	308.33M	168.76M	86.58M	118.07M	-6.02M	91.91M	-74.27M	-93.43M
EBIT	172.54M	159.07M	34.37M	17.64M	56.46M	-21.81M	-19M	-74.86M	-94.08M
Depreciation & Amortization	169.16M	149.26M	134.39M	68.94M	61.61M	15.8M	110.91M	594K	655K